GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pro Medicus Ltd (FRA:PMC) » Definitions » Cash Ratio

Pro Medicus (FRA:PMC) Cash Ratio : 4.48 (As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Pro Medicus Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Pro Medicus's Cash Ratio for the quarter that ended in Jun. 2024 was 4.48.

Pro Medicus has a Cash Ratio of 4.48. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Pro Medicus's Cash Ratio or its related term are showing as below:

FRA:PMC' s Cash Ratio Range Over the Past 10 Years
Min: 2.26   Med: 3.39   Max: 4.48
Current: 4.48

During the past 13 years, Pro Medicus's highest Cash Ratio was 4.48. The lowest was 2.26. And the median was 3.39.

FRA:PMC's Cash Ratio is ranked better than
93.07% of 664 companies
in the Healthcare Providers & Services industry
Industry Median: 0.57 vs FRA:PMC: 4.48

Pro Medicus Cash Ratio Historical Data

The historical data trend for Pro Medicus's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro Medicus Cash Ratio Chart

Pro Medicus Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.41 3.51 3.37 3.94 4.48

Pro Medicus Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.37 3.80 3.94 5.64 4.48

Competitive Comparison of Pro Medicus's Cash Ratio

For the Health Information Services subindustry, Pro Medicus's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pro Medicus's Cash Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Pro Medicus's Cash Ratio falls into.



Pro Medicus Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Pro Medicus's Cash Ratio for the fiscal year that ended in Jun. 2024 is calculated as:

Cash Ratio (A: Jun. 2024 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=95.546/21.317
=4.48

Pro Medicus's Cash Ratio for the quarter that ended in Jun. 2024 is calculated as:

Cash Ratio (Q: Jun. 2024 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=95.546/21.317
=4.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pro Medicus  (FRA:PMC) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Pro Medicus Cash Ratio Related Terms

Thank you for viewing the detailed overview of Pro Medicus's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pro Medicus Business Description

Traded in Other Exchanges
Address
450 Swan Street, Richmond, VIC, AUS, 3121
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.

Pro Medicus Headlines

From GuruFocus

Weekly CFO Buys Highlight: PMC, ZBB

By gurujk gurujk 06-25-2012

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 11-04-2010

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 81,000 Shares

By GuruFocus Research GuruFocus Editor 08-13-2010

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 25,000 Shares

By GuruFocus Research GuruFocus Editor 11-16-2009

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 08-05-2010